Literature DB >> 32208790

Updates and new perspectives in nonmelanoma skin cancer therapy: highlights from 'Immunotherapy Bridge'.

Paolo Antonio Ascierto1, Claus Garbe2.   

Abstract

Over the last few years, extensive research has improved our understanding of tumor immunology and has enabled the development of novel treatments. The state of the art of immunotherapy in various types of malignancies was exhaustively discussed in the 'Immunotherapy Bridge' meeting, which was held in Naples on 4-5 December 2019. Highlights related to the immunological treatment of nonmelanoma skin cancer are the content of this article.

Entities:  

Keywords:  Merkel cell carcinoma; basal cell carcinoma; cutaneous immunotherapy; nonmelanoma skin cancer; squamous cell carcinoma

Mesh:

Substances:

Year:  2020        PMID: 32208790     DOI: 10.2217/imt-2020-0042

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  2 in total

1.  Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter?

Authors:  Iago Gonçalves Ferreira; Ana Letícia Boff; Laura Luzzato; Paulo R Martins Souza; Mariele Bevilaqua
Journal:  Dermatol Pract Concept       Date:  2021-04-12

Review 2.  Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers.

Authors:  Dimitrios C Ziogas; Anastasios Martinos; Dioni-Pinelopi Petsiou; Amalia Anastasopoulou; Helen Gogas
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.